Keywords: astellas, acclerates, cardiome, 10m, fee, japan-based, drug

Astellas acclerates Cardiome's $10M fee

Article | 17 July 2006

Print This

Japan-based drug major Astellas has amended its agreement with Canada's Cardiome over their planned re-submission of the New Drug Application ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in